Anti-WDR17 monoclonal antibody

Pre-made anti-WDR17 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to WDR17/WDR17 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2276-Ab-1/ GM-Tg-hg-IP2276-Ab-2Anti-Human WDR17 monoclonal antibodyHuman
GM-Tg-rg-IP2276-Ab-1/ GM-Tg-rg-IP2276-Ab-2Anti-Rat WDR17 monoclonal antibodyRat
GM-Tg-mg-IP2276-Ab-1/ GM-Tg-mg-IP2276-Ab-2Anti-Mouse WDR17 monoclonal antibodyMouse
GM-Tg-cynog-IP2276-Ab-1/ GM-Tg-cynog-IP2276-Ab-2Anti-Cynomolgus/ Rhesus macaque WDR17 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2276-Ab-1/ GM-Tg-felg-IP2276-Ab-2Anti-Feline WDR17 monoclonal antibodyFeline
GM-Tg-cang-IP2276-Ab-1/ GM-Tg-cang-IP2276-Ab-2Anti-Canine WDR17 monoclonal antibodyCanine
GM-Tg-bovg-IP2276-Ab-1/ GM-Tg-bovg-IP2276-Ab-2Anti-Bovine WDR17 monoclonal antibodyBovine
GM-Tg-equg-IP2276-Ab-1/ GM-Tg-equg-IP2276-Ab-2Anti-Equine WDR17 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2276-Ab-1/ GM-Tg-hg-IP2276-Ab-2; GM-Tg-rg-IP2276-Ab-1/ GM-Tg-rg-IP2276-Ab-2;
GM-Tg-mg-IP2276-Ab-1/ GM-Tg-mg-IP2276-Ab-2; GM-Tg-cynog-IP2276-Ab-1/ GM-Tg-cynog-IP2276-Ab-2;
GM-Tg-felg-IP2276-Ab-1/ GM-Tg-felg-IP2276-Ab-2; GM-Tg-cang-IP2276-Ab-1/ GM-Tg-cang-IP2276-Ab-2;
GM-Tg-bovg-IP2276-Ab-1/ GM-Tg-bovg-IP2276-Ab-2; GM-Tg-equg-IP2276-Ab-1/ GM-Tg-equg-IP2276-Ab-2
Products NameAnti-WDR17 monoclonal antibody
Formatmab
Target NameWDR17
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-WDR17 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2276-Ag-1Recombinant multi-species WDR17 protein


    Target information

    Target IDGM-IP2276
    Target NameWDR17
    Gene ID116966,244484,364653,700546,482934,101084617,783416,100146539
    Gene Symbol and Synonyms3010002I12Rik,B230207L18Rik,WDR17
    Uniprot AccessionQ8IZU2
    Uniprot Entry NameWDR17_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000150627
    Target ClassificationN/A

    The target: WDR17, gene name: WDR17, also named as . This gene encodes a WD repeat-containing protein. It is abundantly expressed in retina and testis, and is thought to be a candidate gene for retinal disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.